income 348 31% 65 2% -81% Selling expense -138 -12% -306 -10% 121% Administrative expense -286 -25% -437 -15% 53% Finance costs -136 -12% -207 -7% 52% Net gains on exchange rate 0 0% 91 3% n/a Share of

% Administrative expense -281 -29% -573 -24% 104% Finance costs -116 -12% -165 -7% 43% Net gains on exchange rate -349 -37% 171 7% 149% Share of loss from investment in joint ventures -33 -3% 33 1% 200% EBT 294 31

this checklist and include it as part of the package of this form Page 2 of 9 Form 35 – ARFP CIS Asia Region Funds Passport (ARFP) CIS Application Form To: Secretary-General Securities and Exchange

Jor. 62/2561 Re: Offer for Sale of Bonds Denominated in Foreign Currency in the Kingdom of Thailand ________________ By virtue of Section 16/6 of the Securities and Exchange Act B.E. 2535 (1992), as

Stock Exchange of Thailand Enclosure: Information Memorandum regarding the Acquisition of Asset of Demeter Corporation Public Company Limited The Meeting of the Board of Directors No. 8/2017 of Demeter

associates increased 69.0% q-on-q from Baht 29 million in Q3’2018 to Baht 49 million in Q4’2018, primarily due to profit increases at our associate namely ABPIF. Gain (Loss) on Exchange Rate • Recorded Loss on

ventures namely ABPIF and BGSENA. Gain (Loss) on Exchange Rate • Recorded Loss on Exchange Rate at Baht 14 million in 9M’2018 and Q3’2018, primarily attributable to a realized loss on exchange rate from

The Stock Exchange of Thailand Enclosure: Information Memorandum on the Asset Disposal, Schedule 1 of Rich Asia Corporation Public Company Limited Reference to the Board of Directors’ meeting of Rich

entitled for subscription of new ordinary shares (Record Date) and Subscription period To: The President of the Stock Exchange of Thailand Enclosure: 1. No. For. 19/2018 Capital Increase, Waiver from

ของกองทุนรวมต่างประเทศเพียงกองทุนเดียว (Feeder Fund) ได้แก่ ARK Genomic Revolution ETF (ARKG) (กองทุนหลัก) ซึ่งเป็นกองทุน ETF ท่ีบริหารแบบเชิงรุก (Actively Managed Exchange Traded Fund) กองทุนหลักจดทะเบียน